financetom
Business
financetom
/
Business
/
SAGE Therapeutics Receives Unsolicited $7.22 Per Share Acquisition Proposal From Biogen
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SAGE Therapeutics Receives Unsolicited $7.22 Per Share Acquisition Proposal From Biogen
Jan 13, 2025 4:06 AM

06:34 AM EST, 01/13/2025 (MT Newswires) -- SAGE Therapeutics ( SAGE ) said late Friday that Biogen (BIIB) had submitted an unsolicited, nonbinding proposal to acquire all outstanding shares of the company not already owned for $7.22 per share.

After consulting with its financial and legal advisors, the company said it would review and determine the best course of action for the company and its shareholders.

SAGE Therapeutics' ( SAGE ) share rose 38% in premarket trading activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved